Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 905432, 12 pages
http://dx.doi.org/10.1155/2015/905432
Review Article

Innovative Thoughts on Treating Diabetes from the Perspective of Traditional Chinese Medicine

1Department of Endocrinology, Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing 100054, China
2Department of Digestion, Beijing Hospital of Traditional Chinese Medicine, Capital University of Medicine Sciences, Beijing 100010, China
3Laboratory of Molecular Biology, Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing 100054, China

Received 24 November 2014; Accepted 10 April 2015

Academic Editor: Musa Toyin Yakubu

Copyright © 2015 Bing Pang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Diabetes Altas Globally, International Diabetes Federation, 6th edition, 2013, http://www.idf.org/diabetesatlas.
  2. W. Y. Yang, J. M. Lu, J. P. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Wang, J. Wang, and P. Chan, “Treating type 2 diabetes mellitus with traditional chinese and indian medicinal herbs,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 343594, 17 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Xie, Y. Zhao, and Y. Zhang, “Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 726723, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Zimmet, K. G. M. M. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. El-Kaissi and S. Sherbeeni, “Pharmacological management of type 2 diabetes mellitus: an update,” Current Diabetes Reviews, vol. 7, no. 6, pp. 392–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Ning, J. Hong, Y. Bi et al., “Progress in diabetes research in China,” Zhong Guo Tang Niao Bing Za Zhi, vol. 1, no. 3, pp. 163–172, 2009. View at Google Scholar
  8. X. L. Tong, L. Dong, L. Chen, and Z. Zhen, “Treatment of diabetes using traditional Chinese medicine: past, present and future,” The American Journal of Chinese Medicine, vol. 40, no. 5, pp. 877–886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. P. Zhu, X. Li, and Z. P. Xu, “The diagnostic and therapeutic system of ‘combination of symptom, syndrome and disease’ in the clinic,” Liao Ning Zhong Yi Za Zhi, vol. 37, no. 10, pp. 1938–1939, 2010. View at Google Scholar
  10. X. L. Tong, “The clinical application on the thought of combination of symptom, syndrome and disease,” Zhong Yi Za Zhi, vol. 51, no. 4, pp. 300–303, 2010. View at Google Scholar
  11. C. Keji and X. Hao, “The integration of traditional Chinese medicine and Western medicine,” European Review, vol. 11, no. 2, pp. 225–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Cheung, “TCM: made in China,” Nature, vol. 480, no. 7378, pp. S82–S83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Chen, “Clinical service of Chinese medicine,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 14, no. 3, pp. 163–164, 2008. View at Google Scholar
  14. Y. Q. Ou, Diagnostics in the Clinic, People's Medical Publishing House, 2005.
  15. Q. Wang, “The present situation of TCM treatment for diabetes and its researches,” Journal of Traditional Chinese Medicine, vol. 23, no. 1, pp. 67–73, 2003. View at Google Scholar · View at Scopus
  16. W. L. Li, H. C. Zheng, J. Bukuru, and N. de Kimpe, “Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Liu, L. Lin, Q. Ni, and M. D. Li, “Curative effect evaluation of ziyi granules for deficiency of both Qi and Yin in type 2 diabetes mellitus patients,” Yi Xue Yan Jiu Za Zhi, vol. 41, no. 1, pp. 42–44, 2012. View at Google Scholar
  18. X. M. Liu, L. Chen, L. Dong et al., “Discussion of formulation and pathogenesis of T2DM,” Shi Jie Zhong Xi Yi Jie He Za Zhi, vol. 2, no. 12, pp. 686–689, 2007. View at Google Scholar
  19. N. G. Clark, K. M. Fox, and S. Grandy, “Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the study to help improve early evaluation and management of risk factors leading to diabetes (SHIELD),” Diabetes Care, vol. 30, no. 11, pp. 2868–2873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Y. Su and W. Y. Yang, “The hyperglycemic process began with monitoring,” Yao Pin Ping Jia, vol. 6, no. 1, pp. 15–16, 2009. View at Google Scholar
  21. C. Daousi, I. F. Casson, G. V. Gill, I. A. MacFarlane, J. P. H. Wilding, and J. H. Pinkney, “Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors,” Postgraduate Medical Journal, vol. 82, no. 966, pp. 280–284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. X. L. Tong, W. K. Liu, J. Wang, Q. Ni, and J. P. Wei, “Key points of syndrome differentiation and practical application of stagnation, heat, deficiency and damage, four stages of diabetes,” Ji Lin Zhong Yi Yao Za Zhi, vol. 32, no. 6, pp. 442–444, 2012. View at Google Scholar
  23. W. D. Li, Y. S. Wang, X. H. Su et al., “Clinical observation on Qingre Quzhuo Capsule for 52 cases of diabetes combined with metabolic syndrome,” Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi, vol. 9, no. 7, pp. 797–798, 2011. View at Google Scholar
  24. Q. Yi, X.-E. He, K.-F. Luo et al., “Protection of long-term treatment with huang-lian-jie-du-tang on vascular endothelium in rats with type 2 diabetes mellitus,” Current Therapeutic Research—Clinical and Experimental, vol. 73, no. 6, pp. 174–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Poitout and R. P. Robertson, “Glucolipotoxicity: fuel excess and β-cell dysfunction,” Endocrine Reviews, vol. 29, no. 3, pp. 351–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Y. Zhou, S. W. Zhou, K. B. Zhang et al., “Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats,” Biological and Pharmaceutical Bulletin, vol. 31, no. 6, pp. 1169–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Yin, H. Xing, and J. Ye, “Efficacy of berberine in patients with type 2 diabetes mellitus,” Metabolism: Clinical and Experimental, vol. 57, no. 5, pp. 712–717, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. C. S. Yang, G. Chen, and Q. Wu, “Recent scientific studies of a traditional Chinese medicine, tea, on prevention of chronic diseases,” Journal of Traditional and Complementary Medicine, vol. 4, no. 1, pp. 17–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Basu, K. Sanchez, M. J. Leyva et al., “Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome,” Journal of the American College of Nutrition, vol. 29, no. 1, pp. 31–40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-Y. Liu, C.-J. Huang, L.-H. Huang, I.-J. Chen, J.-P. Chiu, and C.-H. Hsu, “Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial,” PLoS ONE, vol. 9, no. 3, Article ID e91163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Dregan, J. Charlton, P. Chowienczyk, and M. C. Gulliford, “Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study,” Circulation, vol. 130, no. 10, pp. 837–844, 2014. View at Publisher · View at Google Scholar
  32. W. Xie and L. Du, “Diabetes is an inflammatory disease: evidence from traditional Chinese medicines,” Diabetes, Obesity and Metabolism, vol. 13, no. 4, pp. 289–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Yi, X.-E. He, K.-F. Luo et al., “Protection of long-term treatment with Huang-Lian-Jie-Du-Tang on vascular endothelium in rats with type 2 diabetes mellitus,” Current Therapeutic Research—Clinical and Experimental, vol. 73, no. 6, pp. 174–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Lu, J.-S. Wang, and L.-Y. Kong, “Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 911–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Zeng, X. Liu, S. Dou et al., “Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway,” Journal of Pharmacy and Pharmacology, vol. 61, no. 12, pp. 1699–1707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. J. Wang and Q. Xu, “Mechanism of anti-inflammatory action of Huanglian Jiedu decoction a traditional Chinese prescription,” Zhongguo Zhong Yao Za Zhi, vol. 25, no. 8, pp. 493–496, 2000. View at Google Scholar · View at Scopus
  37. H.-J. Wang and B.-H. Chiang, “Anti-diabetic effect of a traditional Chinese medicine formula,” Food & Function, vol. 3, no. 11, pp. 1161–1169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. F. M. Lian, Z. X. Wei, X. F. Lv et al., “Clinical RCT study on the effect of Kaiyu Qingre Jiangzhuo prescription on type 2 diabetes,” Shi Jie Zhong Xi Yi Jie He Za Zhi, vol. 3, no. 1, pp. 32–35, 2008. View at Google Scholar
  39. H. Taniwaki, T. Shoji, M. Emoto et al., “Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus,” Atherosclerosis, vol. 158, no. 1, pp. 207–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. Z.-H. Fang, Y. Liu, T.-T. Bao et al., “Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions,” World Journal of Gastroenterology, vol. 19, no. 19, pp. 2963–2968, 2013. View at Google Scholar · View at Scopus
  41. Y. L. Wu, Study of Collateral Diseases, China Press of Traditional Chinese Medicine, 2005.
  42. X. L. Tong, “TCM theoretical application on ‘treat disease before it arises’ and ‘unblock the collateral vessels’ in the treatment of diabetes and its complications,” Zhong Yi Za Zhi, vol. 48, no. 6, pp. 484–486, 2007. View at Google Scholar
  43. Y. Y. Song and J. Yang, “Treatment of diabetic vascular complications using the theory of collateral diseases,” Nang Jing Zhong Yi Yao Da Xue Xue Bao, vol. 30, no. 5, pp. 406–409, 2014. View at Google Scholar
  44. X. W. Yang, F. Q. Liu, J. J. Guo et al., “Antioxidation and anti-inflammatory activity of Tang Bi Kang in rats with diabetic peripheral neuropathy,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 66, 2015. View at Publisher · View at Google Scholar
  45. N. Zhang, Y. Gao, D. Zou et al., “Effects of Chinese medicine Tong xinluo on diabetic nephropathy via inhibiting TGF-β1-induced epithelial-to-mesenchymal transition,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 123497, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Gao, Y. Guo, X. Li et al., “An aqueous extract of Radix Astragali, Angelica sinensis, and Panax notoginseng is effective in preventing diabetic retinopathy,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 578165, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. M. Li, X. D. Liu, and L. Qiao, “Application of ‘Ku Suan Zhi Tian’ method in the treatment of Xiao Ke,” Guo Yi Lun Tan, vol. 29, no. 3, pp. 59–60, 2014. View at Google Scholar
  48. W. K. Liu, The Analysis of Regularity of Treating Diabetes with ‘Ku Suan Zhi Tian’ Method on the Basis of Clinic Data Mining, China Academy of Chinese Medical Sciences, 2010.
  49. Q. Qian, W. Chen, W. Yue, Z. Yang, Z. Liu, and W. Qian, “Antiemetic effect of Xiao-Ban-Xia-Tang, a Chinese medicinal herb recipe, on cisplatin-induced acute and delayed emesis in minks,” Journal of Ethnopharmacology, vol. 128, no. 3, pp. 590–593, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Pang, Q. Zhou, J. L. Li et al., “Treatment of refractory diabetic gastroparesis: western medicine and traditional Chinese medicine therapies,” World Journal of Gastroenterology, vol. 20, no. 21, pp. 6504–6514, 2014. View at Publisher · View at Google Scholar
  51. C. Y. Zhang, “Eighty cases of vomiting of pregnancy treated by modified Su Ye Huang Lian Tang,” He Nan Zhong Yi Xue Yuan Xue Bao, vol. 19, no. 4, p. 60, 2004. View at Google Scholar
  52. H. He, X. Yang, X. Zeng et al., “Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats,” Journal of Pharmacy and Pharmacology, vol. 59, no. 9, pp. 1297–1305, 2007. View at Google Scholar
  53. J. L. Chen and F. M. Ling, “The influence of Liu Wei Di Huang Wan on albuminuria in early stage of diabetic nephropathy,” Xin Zhong Yi, vol. 36, no. 12, pp. 26–27, 2004. View at Google Scholar
  54. Z.-M. Lu, Y.-R. Yu, H. Tang, and X.-X. Zhang, “The protective effects of Radix Astragali and Rhizoma Ligustici Chuanxiong on endothelial dysfunction in type 2 diabetic patients with microalbuminuria,” Sichuan Da Xue Xue Bao Yi Xue Ban, vol. 36, no. 4, pp. 529–532, 2005. View at Google Scholar · View at Scopus
  55. T. Z. Wang, Y. Chen, Y. M. He et al., “Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial,” Chinese Journal of Integrative Medicine, vol. 11, no. 3, pp. 175–183, 2013. View at Google Scholar
  56. Y. Tong and H. Hou, “Effects of Huangqi Guizhi Wuwu Tang on diabetic peripheral neuropathy,” Journal of Alternative and Complementary Medicine, vol. 12, no. 6, pp. 506–509, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Feng, W.-K. Liu, L. Deng, J.-X. Tian, and X.-L. Tong, “Clinical efficacy of aconitum-containing traditional Chinese medicine for diabetic peripheral neuropathic pain,” The American Journal of Chinese Medicine, vol. 42, no. 1, pp. 109–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. U. F. Ezuruike and J. M. Prieto, “The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations,” Journal of Ethnopharmacology, vol. 155, no. 2, pp. 857–924, 2014. View at Publisher · View at Google Scholar
  59. Q. Fu, K. Zan, M. Zhao et al., “Triterpene saponins from clematis chinensis and their potential anti-inflammatory activity,” Journal of Natural Products, vol. 73, no. 7, pp. 1234–1239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Kang and S. Koppula, “Olea europaea Linn. Fruit Pulp extract protects against carbon tetrachloride-induced hepatic damage in mice,” Indian Journal of Pharmaceutical Sciences, vol. 76, no. 4, pp. 274–280, 2014. View at Google Scholar
  61. S. H. Hong, S. H. Seo, J. H. Lee, and B. T. Choi, “The aqueous extract from Artemisia capillaris Thunb. inhibits lipopolysaccharide-induced inflammatory response through preventing NF-kappaB activation in human hepatoma cell line and rat liver,” International Journal of Molecular Medicine, vol. 13, no. 5, pp. 717–720, 2004. View at Google Scholar · View at Scopus
  62. H. Zhang, C.-H. Yu, Y.-P. Jiang et al., “Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice,” PLoS ONE, vol. 7, no. 9, Article ID e46574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. X. L. Tong, Y. S. Wang, Y. L. Fu et al., “Discussion on dose-effect relationship of medicinals and formulas,” Zhong Yi Za Zhi, vol. 51, no. 11, pp. 965–967, 2010. View at Google Scholar
  64. J. Xu, F. M. Lian, L. H. Zhao et al., “Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula,” International Society for Microbial Ecology Journal, vol. 9, no. 3, pp. 552–562, 2015. View at Google Scholar
  65. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China, China Medical Science Press, 2010.
  66. J. Li, M. Li, B. Pang et al., “Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis,” World Journal of Gastroenterology, vol. 20, no. 26, pp. 8674–8680, 2014. View at Publisher · View at Google Scholar
  67. C. Vincent and A. Furnham, “Why do patients turn to complementary medicine? An empirical study,” The British Journal of Clinical Psychology, vol. 35, no. 1, pp. 37–48, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. L. J. N. Ji and G. Z. Yin, “The general situation of treating obese type 2 diabetes mellitus with acupuncture,” Xin Jiang Zhong Yi Yao Za Zhi, vol. 32, no. 1, pp. 72–75, 2014. View at Google Scholar
  69. T.-F. Tzeng, S.-S. Liou, and I.-M. Liu, “The selected traditional chinese medicinal formulas for treating diabetic nephropathy: perspective of modern science,” Journal of Traditional and Complementary Medicine, vol. 3, no. 3, pp. 152–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. F. M. Lian, G. Li, X. Chen et al., “Chinese herbal medicine tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial,” Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 2, pp. 648–655, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Xu and K.-J. Chen, “Making evidence-based decisions in the clinical practice of integrative medicine,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, vol. 16, no. 6, pp. 483–485, 2010. View at Publisher · View at Google Scholar · View at Scopus